Neuland Labs profit drops sharply in Q3 as sales slow and costs bite

The drug firm reported ₹439.7 crore in revenue, down 10.5% on a year-on-year basis and 14.8% on sequential basis. Revenue in the same quarter last year stood at ₹398 crore while previous quarter reported ₹516 crore.








